NasdaqGS - Delayed Quote USD

Lifecore Biomedical, Inc. (LFCR)

6.87
0.00
(0.00%)
At close: 4:00:01 PM EDT
6.87
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Total Revenue
130,309
128,261
103,269
111,270
100,874
Cost of Revenue
86,721
86,411
75,284
72,204
61,937
Gross Profit
43,588
41,850
27,985
39,066
38,937
Operating Expense
55,608
49,038
47,705
42,498
34,405
Operating Income
-12,020
-7,188
-19,720
-3,432
4,532
Net Non Operating Interest Income Expense
-22,104
-18,090
-17,581
-15,470
-8,885
Other Income Expense
-10,579
34,792
-26,627
-1,785
-25,434
Pretax Income
-44,703
9,514
-63,928
-20,687
-29,787
Tax Provision
-47
183
308
-5,211
-6,350
Net Income Common Stockholders
-49,395
12,013
-99,563
-116,715
-32,294
Diluted NI Available to Com Stockholders
-49,395
12,013
-99,563
-116,715
-32,294
Basic EPS
-1.47
0.40
-3.41
-3.29
-1.11
Diluted EPS
-1.47
0.32
-3.41
-3.30
-1.12
Basic Average Shares
33,196.79
30,474
29,967.74
29,513
29,332.83
Diluted Average Shares
34,866.39
36,658
29,967.74
29,513
29,332.83
Total Operating Income as Reported
-20,423
-8,844
-21,796
-11,791
-8,823
Total Expenses
142,329
135,449
122,989
114,702
96,342
Net Income from Continuing & Discontinued Operation
-44,653
12,013
-99,563
-116,715
-32,294
Normalized Income
-35,362.78
-27,782.61
-43,840.57
-9,222.63
-12,055.65
Interest Income
--
--
68
81
48
Interest Expense
22,104
18,090
17,581
15,470
8,933
Net Interest Income
-22,104
-18,090
-17,581
-15,470
-8,885
EBIT
-22,599
27,604
-46,347
-5,217
-20,854
EBITDA
-13,567
36,463
-33,170
12,844
-987
Reconciled Cost of Revenue
86,721
86,411
75,284
72,204
61,937
Reconciled Depreciation
9,032
8,859
13,177
18,061
19,867
Net Income from Continuing Operation Net Minority Interest
-44,656
9,331
-64,236
-15,476
-23,437
Total Unusual Items Excluding Goodwill
-9,303
37,844
-25,817
-8,359
-14,465
Total Unusual Items
-9,303
37,844
-25,817
-8,359
-14,465
Normalized EBITDA
-4,264
-1,381
-7,353
21,203
13,478
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9.78
730.39
-5,421.57
-2,105.63
-3,083.65
5/31/2021 - 2/15/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANIK Anika Therapeutics, Inc.
11.59
+1.22%
 
CPIX Cumberland Pharmaceuticals Inc.
5.78
+1.23%
 
KMDA Kamada Ltd.
6.73
-2.46%
 
AMRX Amneal Pharmaceuticals, Inc.
7.45
+0.40%
 
EBS Emergent BioSolutions Inc.
6.41
+1.91%
 
TAK Takeda Pharmaceutical Company Limited
14.97
-0.70%
 
KNSA Kiniksa Pharmaceuticals International, plc
29.11
+4.26%
 
RDY Dr. Reddy's Laboratories Limited
14.66
-0.44%
 
HLN Haleon plc
11.05
-3.20%
 
UTHR United Therapeutics Corporation
324.20
-0.39%